Spelling suggestions: "subject:"bonemarrow"" "subject:"marrow""
711 |
TLR Activation Prevents Hematopoietic Chimerism Induced by Costimulation Blockade: A DissertationMiller, David M. 20 May 2008 (has links)
Costimulation blockade based on a donor-specific transfusion and anti-CD154 mAb is effective for establishing mixed allogeneic hematopoietic chimerism and inducing transplantation tolerance. Despite its potential, recent evidence suggests that the efficacy of costimulation blockade can be reduced by environmental perturbations such as infection or inflammation that activate toll-like receptors (TLR). TLR agonists prevent costimulation blockade-induced prolongation of solid organ allografts, but their effect on the establishment of hematopoietic chimerism has not been reported.
In this dissertation, we hypothesized that TLR activation during costimulation blockade would prevent the establishment of mixed hematopoietic chimerism and shorten skin allograft survival. To test this hypothesis, costimulation blockade-treated mice were co-injected with TLR2 (Pam3Cys), TLR3 (poly I:C), or TLR4 (LPS) agonists and transplanted with allogeneic bone marrow and skin grafts. Supporting our hypothesis, we observed that TLR agonists administered at the time of costimulation blockade prevented the establishment of mixed hematopoietic chimerism and shortened skin allograft survival.
To investigate underlying cellular and molecular mechanisms, we first determined that LPS administration during costimulation blockade did not increase production of alloantibodies or activate natural killer cells. Similarly, costimulation blockade-treated mice depleted of CD4+ or CD8+ cells did not become chimeric when co-injected with LPS. In contrast, mice depleted of both CD4+ and CD8+cell subsets were resistant to the effects of LPS.
We next observed that alloreactive T cells were activated by TLR agonists in mice treated with costimulation blockade, and this activation correlated with LPS-induced maturation of donor and host alloantigen-presenting cells. In contrast, TLR4-deficient mice treated with costimulation blockade and LPS did not upregulate costimulatory molecules on their APCs, and mixed chimerism and permanent skin allograft survival were readily achieved. We further observed that injection of recombinant IFN-β recapitulated the detrimental effects of LPS, and that LPS-injected mice deficient in the type I IFN receptor were partially protected. Importantly, alloantigen-presenting cells did not upregulate costimulatory molecules in response to LPS, and mixed chimerism and permanent skin allograft survival were readily established in type I IFN receptor and MyD88 double deficient mice treated with costimulation blockade. We conclude that the TLR4 agonist LPS prevents the establishment of mixed hematopoietic chimerism and shortens skin allograft survival in mice treated with costimulation blockade by inducing the production of type 1 IFN and MyD88-dependent factors that upregulate costimulatory molecules on APCs, leading to the generation of activated alloreactive T cells.
|
712 |
Function and compartmentalization of circulating versus tissue resident memory T cellsCendón, Carla 13 March 2019 (has links)
Verstärkte Anstrengungen zur Förderung der T-Zell-basierten Immunität haben eine zwingende Notwendigkeit für unser Verständnis der menschlichen T-Zell-Funktion und –Erhaltung geschaffen. Das Paradigma, dass Gedächtnis-T-Lymphozyten kontinuierlich durch den Körper zirkulieren wurde vor kurzem durch die Entdeckung der Gedächtnis-T-Zellen, die in einer Vielzahl von Geweben, einschließlich des Knochenmarks angesiedelt sind, herausgefordert. Allerdings bleibt der Unterschied zwischen Funktionsweise von zirkulierenden und gewebeansässigen Gedächtnis-T-Zellen nur unzulänglich verstanden.
Die Knochenmark ist die Heimat für eine große Anzahl Gedächtnis-T-Zellen. CD4+ Gedächtnis-T-Zellen aus dem Knochenmark beinhalten ein breites Spektrum an Antigenspezifitäten. Interessanterweise wurden CD4+ Gedächtnis-T-Zellen spezifisch für systemische Kindheitsantigene im Knochenmark von älteren Menschen gefunden, auch wenn sie nicht mehr in der Blutzirkulation nachgewiesen werden konnten. Gedächtnis-T-Zellen aus dem Knochenmark sind sesshaft und ruhend und Langzeitgedächtnis gegen systemische Antigene erhalten. Sowohl der Überlebensmechanismus von Gedächtnis-T-Zellen, als auch die Kapazität von gewebsansässigen Gedächtnis-T-Zellen nach einer systemischen Herausforderung mobilisiert zu werden, sind bisher nur unzureichend geklärt.
Ich habe gezeigt, dass Gedächtnis-T-Zellen aus dem peripheren Blut und Knochenmark unterschiedliche Überlebensfähigkeiten haben. Weiterhin habe ich die Rolle von Überleben Faktoren in ihrer Erhaltung identifiziert. Zudem habe ich bestimmt, dass Gedächtnis-T-Zellen aus dem Blut und Knochenmark unterschiedliche Zellpopulationen sind, mit unterschiedliche TCRβ Repertoires. Schließlich konnte ich zeigen, dass sesshafte Gedächtnis-T-Zellen, die spezifisch für systemische Antigene sind, schnell in die Blutzirkulation mobilisiert werden. Zusammenfassend bieten diese Studien ein umfassenderes Verständnis der Funktion und des Erhalts des immunologischen Gedächtnisses. / Intensified efforts to promote protective T cell-based immunity in vaccines and immunotherapies have created a compelling need to expand our understanding of human T cell function and maintenance. The paradigm that memory T lymphocytes are continuously circulating through the body in search of their cognate antigen has been recently challenged by the discovery of memory T cells residing in a variety of tissues, including the bone marrow (BM). However, the division of labor and lifestyle of circulating versus tissue resident memory T cells remains poorly understood.
The human BM is home to a great number of memory T cells. BM memory CD4+ T cells contain a wide array of antigen specificities. Interestingly, memory CD4+ T cells specific for systemic childhood antigens have been found in the BM of elderly humans, even when they were no longer detectable in peripheral blood (PB) circulation. BM memory T cells are resident, resting and maintain long-term memory to systemic antigens. The survival mechanisms of circulating and BM resident memory T cells; as well as the capacities of tissue resident memory T cells to be mobilized into blood circulation after systemic antigen re-challenge to confer us with immune protection remains to be elucidated.
I have shown that PB and BM memory T cells have different survival capacities, as well as identified the role of survival factors in their maintenance. Moreover, using sequencing analysis of the TCRβ repertoire, I have determined that PB and BM memory T cells are separated cell populations. Finally, by tracking the dynamics of antigen-specific memory CD4+ T cells after systemic MMR re-vaccination I could show that TRM CD4+ T cells specific for systemic antigens can be rapidly mobilized into blood circulation and contribute to the immune response. These studies provide a more comprehensive understanding of the function and maintenance of immunological memory in humans.
|
713 |
Functional role of the TLR4 signaling pathway in the bone marrow response to sepsisZhang, Huajia 31 March 2015 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Sepsis is a clinical syndrome due to a systemic inflammatory response to severe microbial infection. Little is known about the changes in the bone marrow (BM) and how they affect the hematopoietic response to bacterial infection. Using an animal model of severe sepsis induced by Pseudomonas aeruginosa, we have previously reported that hematopoietic stem cells (HSC) undergo a significant expansion in the BM accompanied with myeloid suppression. This bone marrow response was Toll-like Receptor 4 (TLR4)-dependent. TLR4 is activated by bacterial lipopolysaccharide (LPS) and signals through two major independent downstream molecules: TRIF and MyD88. In the present study, I found that the TLR4/TRIF and the TLR4/MyD88 pathways contribute in a distinct manner to the BM response to P. aeruginosa's LPS. TRIF plays a major role in the expansion of the HSC pool, whereas MyD88 is required for myeloid suppression. Following LPS stimulation, HSCs enter in the cell cycle, expand and exhaust when transplanted in healthy mice. Loss of TRIF rescued completely the long-term engraftment and multilineage reconstitution potential of septic HSCs, but did not affect myeloid differentiation. Conversely, MyD88 deficiency prevented completely the myeloid suppression in the myeloid progenitors, but conferred limited protective effects on the HSC function.
It is of great therapeutic value to identify the downstream molecules involved in TLR4/MyD88 dependent myeloid suppression. I found miR-21, a microRNA that is involved in inflammation, was up-regulated upon LPS challenge in a MyD88-dependent manner. However, deletion of miR-21 in the BM did not rescue LPS-induced bone marrow dysfunction, demonstrating that miR-21 is not a critical regulator in these processes. Further studies are warranted to determine the precise molecular mechanisms involved in the complex pathogenesis of BM response to sepsis. Taken together, my results show for the first time that the TLR4/TRIF signaling as a key mediator of HSC damage during acute LPS exposure and that activation of the TLR4/MyD88 signaling pathway play a dominant role in myeloid suppression. These results provide novel insights into our understanding of the molecular mechanisms underlying bone marrow injury during severe sepsis and may lead to the development of new therapeutic approaches in this disease.
|
714 |
Immunobiology and Novel Therapeutics in Acute Graft-versus-Host DiseaseZitzer, Nina Celia 08 October 2018 (has links)
No description available.
|
715 |
Genetic Associations in Acute Leukemia Patients after Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell TransplantationRizvi, Abbas Ali 03 July 2019 (has links)
No description available.
|
716 |
Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic SyndromesKaur Bains, Amanpreet, Behrens Wu, Lena, Rivière, Jennifer, Rother, Sandra, Magno, Valentina, Friedrich, Jens, Werner, Carsten, Bornhäuser, Martin, Götze, Katharina S., Cross, Michael, Platzbecker, Uwe, Wobus, Manja 22 February 2024 (has links)
Myelodysplastic syndromes (MDS) comprise a heterogeneous group of hematologic malignancies characterized by clonal hematopoiesis, one or more cytopenias such as anemia, neutropenia, or thrombocytopenia, abnormal cellular maturation, and a high risk of progression to acute myeloid leukemia. The bone marrow microenvironment (BMME) in general and mesenchymal stromal cells (MSCs) in particular contribute to both the initiation and progression of MDS. However, little is known about the role of MSC-derived extracellular matrix (ECM) in this context. Therefore, we performed a comparative analysis of in vitro deposited MSC-derived ECM of different MDS subtypes and healthy controls. Atomic force microscopy analyses demonstrated that MDS ECM was significantly thicker and more compliant than those from healthy MSCs. Scanning electron microscopy showed a dense meshwork of fibrillar bundles connected by numerous smaller structures that span the distance between fibers in MDS ECM. Glycosaminoglycan (GAG) structures were detectable at high abundance in MDS ECM as white, sponge-like arrays on top of the fibrillar network. Quantification by Blyscan assay confirmed these observations, with higher concentrations of sulfated GAGs in MDS ECM. Fluorescent lectin staining with wheat germ agglutinin and peanut agglutinin demonstrated increased deposition of N-acetyl-glucosamine GAGs (hyaluronan (HA) and heparan sulfate) in low risk (LR) MDS ECM. Differential expression of N-acetyl-galactosamine GAGs (chondroitin sulfate, dermatan sulfate) was observed between LR- and high risk (HR)-MDS. Moreover, increased amounts of HA in the matrix of MSCs from LR-MDS patients were found to correlate with enhanced HA synthase 1 mRNA expression in these cells. Stimulation of mononuclear cells from healthy donors with low molecular weight HA resulted in an increased expression of various pro-inflammatory cytokines suggesting a contribution of the ECM to the inflammatory BMME typical of LR-MDS. CD34+ hematopoietic stem and progenitor cells (HSPCs) displayed an impaired differentiation potential after cultivation on MDS ECM and modified morphology accompanied by decreased integrin expression which mediate cell-matrix interaction. In summary, we provide evidence for structural alterations of the MSC-derived ECM in both LR- and HR-MDS. GAGs may play an important role in this remodeling processes during the malignant transformation which leads to the observed disturbance in the support of normal hematopoiesis.
|
717 |
Endothelial HIF-2alpha controls Cellular Migration in the Bone MarrowGaete Alvarez, Diana Estefania 13 November 2023 (has links)
Establishment and maintenance of the blood system relies on the cellular and spatial organization of bone marrow. In the BM niche, sinusoidal endothelial cells (SECs) are mainly located in the trabecular zone of the metaphysis area of long bones. SECs present a fenestrated structure characterized by high permeability, low shear rates, and oxygen pressure. The hypoxic environment surrounding SECs is needed for the movement and engraftment of hematopoietic cells, but it might also facilitate the homing of malignant cells. SECs’ adaptive response to hypoxia depends on the Hypoxia Inducible Factors (HIFs) promoting angiogenesis, hematopoiesis, and other processes. The upstream regulator of HIFs, the prolyl hydroxylase domain-2 (PHD2) is considered the key cellular oxygen sensor. Our group has shown the crucial regulatory effects that PHD2 has on different physiological and pathological settings. During steady state, PHD2 modulates proliferation and mobilization of hematopoietic progenitor cells (HSCPs), as well as bone metabolism. On the other hand, PHD2 is crucial for neutrophil motility affecting their extravasation during arthritis. We have also demonstrated that loss of PHD2 in different humans and mouse tumor cell lines, as well as in myeloid cells and T-lymphocytes where it impairs tumor development. Others have shown that heterozygous deletion of PHD2 in tumor ECs can reduce distant metastasis. Due to the intricate interplay between the different players of the PHD2/HIFs axis, as well as their effect on other signaling pathways, the positive or negative impact of the hypoxia pathways has been shown to be cell type and context dependent. In the present study, we analyzed the role of hypoxia pathway proteins, mainly PHD2, in ECs in the bone/BM niche, as well as its consequent influence on the environment during physiological and pathological scenarios. We have demonstrated that endothelial PHD2 has a profound intrinsic effect on vessel morphology and functionality, affecting the crucial communication between ECs and the bone/BM niche. Further, using different transgenic mouse lines, we have identified the BM endothelial cells (BM-ECs) PHD2/HIF-2α axis directly increasing leukocytosis via vascular cell adhesion protein 1 (VCAM-1) protein downregulation. Moreover, during steady state conditions we have discovered a novel regulatory effect that PHD2 exerts on VCAM-1 by increasing miR-126-3p transcription, a well-known inhibitor of VCAM-1 expression. Lastly, the PHD2/HIF-2/miR-126-3p/VCAM-1 axis not only influenced the myeloid cell intravasation towards circulation but also increased the extravasation and homing of metastatic breast carcinoma cells into the bone/BM tissue, increasing tumor burden throughout the bone.
BM-ECs PHD2 offers a protective role against tumor homing cells in the bone/BM while serving as an important regulator in the communication between endothelium and BM niche. Concluding Remarks: Loss of PHD2 in ECs generates profound changes in vessel function and in the hematopoietic compartment leading to increase myelopoiesis resulting in leukocytosis. The above-mentioned effect occurs in a HIF-2α-dependent manner. PHD2/HIF-2α also transcribed in an increase of miR-126-3p expression leading to VCAM-1 downregulation. Process that resulted in increased leukocytes in circulation due to hematopoiesis dysregulation. The novel PHD2/HIF-2/miR-126-3p/VCAM-1 axis enhanced extravasation and homing of metastatic breast carcinoma cells into the bone/BM tissue, increasing tumor burden throughout the bone.:Introduction 8
The Endothelium 9
Endothelial barrier. 9
Leukocyte transendothelial migration. 11
Intracellular mechanism for activation of adhesion molecules. 12
Cellular migration in pathological conditions. 13
Tumor Dissemination: Metastasis. 14
Metastatic cascade. 15
The bone is a preferential site for malignant cells arrival. 16
Bone/BM physiology influences metastasis. 17
The endosteal niche. 18
The perivascular niche. 19
Hypoxia pathway proteins impact on metastasis. 20
Thesis Aims 23
Aim 1: Characterize the role of the hypoxia pathway proteins in bone vasculature and the impact on the niche. 24
Aim 2: Analyze the genetic changes that resulted from PHD2 deletion in BM-ECs and their impact on the cross-talk communication with the different BM-niches. 24
Aim 3: Investigate the impact of PHD2 and downstream regulators (HIF-1/2α) on vessel functionality. 25
Materials and Methods 26
Mice. 27
Histology: tissue processing and immunofluorescence staining 28
Bone tissue processing. 28
Staining of Bone cryosections. 28
Induced skin inflammatory model. 29
Staining of ears treated with PMA. 29
Vascular morphology quantification. 29
Microscopy 31
Antibodies used for immunofluorescence. 31
Bone analysis. 31
Bone µCT measurements and analysis 31
Tartrate-resistant acid phosphatase (TRAP) staining 32
Blood and BM analysis. 32
Sysmex. 32
Flow cytometry. 32
BM cell extraction from bones. 32
BM cells staining. 33
Meso Scale Discovery (MSD) 35
Evans Blue assay. 35
BM soup ELISA. 35
RNAseq of CD31+ EMCN+ BM-ECs 36
BM-EC cell sorting for RNAseq. 36
RNA extraction and qPCRs 36
Tumor model. 36
Tumor breast carcinoma cells. 36
Tumor homing model. 37
Statistical analyses. 37
Results 38
PHD2 Conditional Knockout from Endothelial Cell Compartment. 39
Further P2EC mice characterization. 41
Transgenic deletion of PHD2 showed slight developmental retardation. 41
Spleen size showed not to be affected by deletion endothelial PHD2. 41
P2EC mice displayed increased vessel leakiness. 42
Endothelial PHD2 deletion does not affect lung endothelial cells. 43
BM-ECs PHD2-HIF-2α axis modulates leukocytosis and vessel morphology. 44
HIF-2α modulates P2EC leukocytosis and thrombocytopenia. 44
BM-ECs PHD2 deficient mice hinder vessel morphology in a HIF-2α dependent manner. 44
Endothelial PHD2-deficient mice exhibit perturbed hematopoiesis. 45
P2EC mice early progenitor displayed reduced total cell number, but frequency remained unchanged. 46
P2EC mice favor differentiation of committed progenitors with a myeloid bias. 48
P2EC mice significantly reduced the numbers and frequency of megakaryocyte/erythroid progenitor’s linage. 48
PHD2-HIF-2α deletion restored normal hematopoiesis. 50
P2EC vascular functionality during pathological conditions. 53
Endothelial PHD2 modulates leukocyte migration during localized inflammation. 53
Endothelial PHD2 shapes bone/BM tumor homing. 55
Tumor homing in the bone: generation of an early metastatic model. 56
Early metastasis limitation. 58
Endothelial PHD2 modulates tumor colonization to the bone/BM. 59
Simultaneous deletion of PHD2 and HIF-1 in BM-ECs worsen tumor metastasis to bone. 61
Simultaneous deletion of PHD2 and HIF-2 in BM-ECs showed no differences in tumor homing. 62
Deep sequencing of PHD2 deficient BM-ECs. 63
BM EC from P2EC mice display enriched leukocyte migration gene signatures. 63
P2EC mice presented genetic dysfunction in the integrin-binding system. 64
P2EC steady-state VCAM-1 expression is HIF-2α dependent. 66
BM-ECs VCAM-1 + is regulated by PHD2 through HIF-2α. 66
PHD2-dependent downregulation of VCAM-1 does not affect VE-cadherin expression. 68
BM pro-inflammatory cytokines do not contribute to VCAM-1 lower expression. 69
During steady-state, loss of VCAM-1 increased frequency BM resident mature cells. 69
BM-ECs VCAM-1 deficient mice 71
VCAM1EC mice developed leukocytosis. 71
VCAM1EC does not exhibit significant changes in hematopoiesis. 73
P2EC vessel morphology is independent of downregulation of VCAM-1 74
VCAMEC mice showed increased tumor homing in the diaphysis. 75
PHD2-HIF-2 regulatory effect on VCAM-1 is modulated by mir-126-3p. 76
HIF-2α regulates mir-126 expression in PHD2 deficient BM-ECs. 77
BM-ECs PHD2 influence bone homeostasis. 78
Loss of BM-ECs PHD2 lead to increase Osteoclast numbers and activity. 79
Osteoclast differentiation and activity could be independent of OBs. 79
Loss of PHD2 in BM-ECs leads to osteoclastogenesis. 80
BM resident Tcell CD8+ could be Increasing Osteoclast Activation. 82
Discussion. 83
Mouse Model: Conditional Deletion of Endothelial PHD2. 85
Endothelial PHD2 Modulates Myelopoiesis. 86
BM-EC PHD2 regulates vessel morphology and functionality under steady-state independent of VCAM-1. 88
Endothelial VCAM-1 downregulation does not impaired neutrophil migration during inflammation. 88
BM-ECs PHD2 is a Gatekeeper of Tumor Homing in the Bone. 89
HIF-2α dependent Mir-126 activation leads to VCAM-1 downregulation 91
Endothelial PHD2 controls Osteoclastogenesis independent of BM RANKL. 94
References 96
List of Abbreviations 107
Summary 109
Zusammenfassung 111
Acknowledgements 113
Deklaration 114
Appendix 118
List of Figures. 118
List of tables 119 / Die Organisation und Aufrechterhaltung des Blutsystems hängt von der zellulären und räumlichen Organisation des Knochenmarks ab. In der BM-Nische befinden sich, hauptsächlich in der Trabekelzone des Metaphysenbereichs langer Knochen, die sinusoidale Endothelzellen (SECs). SECs weisen eine gefensterte Struktur auf, die von hoher Durchlässigkeit, geringer Scherrate und Sauerstoffdruck geprägt ist. Das hypoxische Milieu der SECs ist notwendig für Bewegung und Einwanderung der hämatopoetischen Zellen und könnte dies ebenso für bösartige Zellen begünstigen. Die Anpassung der SECs an Hypoxie hängt von den Hypoxia Inducible Factors (HIFs) ab. HIFs fördern die Angiogenese, die Hämatopoese und andere Prozesse. Die prolyl hydorxylase domain-2 (PHD2) ist der vorgeschaltete Regulator der HIFs und gilt als wichtigster zellulärer Sauerstoffsensor. Unsere Gruppe konnte zeigen welche zentralen regulatorischen Effekte die PHD2 auf verschiedene physiologische und pathophysiologische Mechanismen ausübt. Im Gleichgewichtszustand moduliert PHD2 Proliferation und Mobilisation der hämatopoetischen Vorläuferzellen (HSCPs) sowie den Knochenmetabolismus. Auf der einen Seite spielt PHD2 eine entscheidende Rolle bei der Motilität der Neutrophilen und beeinflusst daher die Extravasation bei Arthritis. Wir konnten außerdem zeigen, dass der Verlust von PHD2 in verschiedenen humanen und murinen Tumorzelllinien, sowie in myeloischen Zellen und T-Lymphozyten die Tumorentwicklung beeinträchtigt. In anderen Arbeiten wurde gezeigt, dass eine heterozygote PHD2-Deletion in Tumor-ECs eine Fernmetastasierung reduziert. In Anbetracht der komplizierten Wechselwirkung zwischen den verschiedenen Komponenten der PHD2/HIF-Signalkaskade sowie deren Effekte auf andere Signalkaskaden, übt sich in Abhängigkeit des Zelltyps und des Kontexts ein positiver oder negativer Einfluss auf die Hypoxie-Signalwege aus. In der vorliegenden Studie haben wir die Rolle von Proteinen des Hypoxiewegs, hauptsächlich PHD2, in den ECs der Knochen-/BM-Nische sowie deren daraus resultierenden Einfluss auf die Umwelt in physiologischen und pathologischen Szenarien analysiert. Wir konnten zeigen, dass das endotheliale PHD2 einen tiefgreifenden intrinsischen Effekt auf die Gefäßmorphologie und Funktionalität besitzt und damit entscheidend die Kommunikation zwischen ECs und der Knochen-/BM-Nische beeinflusst. Weiterhin konnte unter Nutzung verschiedener transgener Muslinien identifiziert werden, dass die Knochenmarksendothelzellen (BM-ECs) PHD2/HIF-2α-Achse direkt die Myelopoese, durch eine Herabsetzung der vascular cell adhesion protein 1 (VCAM-1) -Expression, steigert. Darüber hinaus haben wir einen neuartigen regulatorischen Effekt der PHD2 auf das VCAM-1 entdeckt. Hierbei wird die Expression des VCAM-1 Inhibitors miR-126-3p gesteigert. Des Weiteren beeinflusst die PHD2/HIF-2/miR-126-3p/VCAM-1 Achse nicht nur die Intravasation der Myloidzellen in Richtung des Kreislaufs, sondern auch eine Steigerung der Extravastion und Einwanderung von metastasierenden Brustkarzinomzellen in die Knochen/BM-Gewebe und steigert somit die Tumorlast in den Knochen. In Anbetracht klinischer Versuche der Krebsbehandlung mit PHD2-Inhibitoren, bietet BM-ECs PHD2 einen schützenden Effekt gegen Tumorzelleinwanderung in die Knochen/BM, während es gleichzeitig als ein wichtiger Regulator in der Kommunikation zwischen Endothelium und der BM-Nische dient. Abschließende Bemerkungen: Der Verlust von PHD2 in ECs führt zu tiefgreifenden Veränderungen in der Gefäßfunktion und im hämatopoetischen Kompartiment, was zu einer verstärkten Myelopoese und damit zu Leukozytose führt. Die oben erwähnte Wirkung tritt in einer HIF-2α-abhängigen Weise auf. PHD2/HIF-2α führte auch zu einem Anstieg der miR-126-3p-Expression, was zu einer Herunterregulierung von VCAM-1 führte. Dieser Prozess führte zu einer erhöhten Anzahl von Leukozyten im Blutkreislauf aufgrund einer Dysregulation der Hämatopoese. Die neuartige PHD2/HIF-2/miR-126-3p/VCAM-1-Achse förderte die Extravasation und Ansiedlung von metastatischen Brustkrebszellen im Knochen/BM-Gewebe, wodurch die Tumorlast im gesamten Knochen erhöht wurde.:Introduction 8
The Endothelium 9
Endothelial barrier. 9
Leukocyte transendothelial migration. 11
Intracellular mechanism for activation of adhesion molecules. 12
Cellular migration in pathological conditions. 13
Tumor Dissemination: Metastasis. 14
Metastatic cascade. 15
The bone is a preferential site for malignant cells arrival. 16
Bone/BM physiology influences metastasis. 17
The endosteal niche. 18
The perivascular niche. 19
Hypoxia pathway proteins impact on metastasis. 20
Thesis Aims 23
Aim 1: Characterize the role of the hypoxia pathway proteins in bone vasculature and the impact on the niche. 24
Aim 2: Analyze the genetic changes that resulted from PHD2 deletion in BM-ECs and their impact on the cross-talk communication with the different BM-niches. 24
Aim 3: Investigate the impact of PHD2 and downstream regulators (HIF-1/2α) on vessel functionality. 25
Materials and Methods 26
Mice. 27
Histology: tissue processing and immunofluorescence staining 28
Bone tissue processing. 28
Staining of Bone cryosections. 28
Induced skin inflammatory model. 29
Staining of ears treated with PMA. 29
Vascular morphology quantification. 29
Microscopy 31
Antibodies used for immunofluorescence. 31
Bone analysis. 31
Bone µCT measurements and analysis 31
Tartrate-resistant acid phosphatase (TRAP) staining 32
Blood and BM analysis. 32
Sysmex. 32
Flow cytometry. 32
BM cell extraction from bones. 32
BM cells staining. 33
Meso Scale Discovery (MSD) 35
Evans Blue assay. 35
BM soup ELISA. 35
RNAseq of CD31+ EMCN+ BM-ECs 36
BM-EC cell sorting for RNAseq. 36
RNA extraction and qPCRs 36
Tumor model. 36
Tumor breast carcinoma cells. 36
Tumor homing model. 37
Statistical analyses. 37
Results 38
PHD2 Conditional Knockout from Endothelial Cell Compartment. 39
Further P2EC mice characterization. 41
Transgenic deletion of PHD2 showed slight developmental retardation. 41
Spleen size showed not to be affected by deletion endothelial PHD2. 41
P2EC mice displayed increased vessel leakiness. 42
Endothelial PHD2 deletion does not affect lung endothelial cells. 43
BM-ECs PHD2-HIF-2α axis modulates leukocytosis and vessel morphology. 44
HIF-2α modulates P2EC leukocytosis and thrombocytopenia. 44
BM-ECs PHD2 deficient mice hinder vessel morphology in a HIF-2α dependent manner. 44
Endothelial PHD2-deficient mice exhibit perturbed hematopoiesis. 45
P2EC mice early progenitor displayed reduced total cell number, but frequency remained unchanged. 46
P2EC mice favor differentiation of committed progenitors with a myeloid bias. 48
P2EC mice significantly reduced the numbers and frequency of megakaryocyte/erythroid progenitor’s linage. 48
PHD2-HIF-2α deletion restored normal hematopoiesis. 50
P2EC vascular functionality during pathological conditions. 53
Endothelial PHD2 modulates leukocyte migration during localized inflammation. 53
Endothelial PHD2 shapes bone/BM tumor homing. 55
Tumor homing in the bone: generation of an early metastatic model. 56
Early metastasis limitation. 58
Endothelial PHD2 modulates tumor colonization to the bone/BM. 59
Simultaneous deletion of PHD2 and HIF-1 in BM-ECs worsen tumor metastasis to bone. 61
Simultaneous deletion of PHD2 and HIF-2 in BM-ECs showed no differences in tumor homing. 62
Deep sequencing of PHD2 deficient BM-ECs. 63
BM EC from P2EC mice display enriched leukocyte migration gene signatures. 63
P2EC mice presented genetic dysfunction in the integrin-binding system. 64
P2EC steady-state VCAM-1 expression is HIF-2α dependent. 66
BM-ECs VCAM-1 + is regulated by PHD2 through HIF-2α. 66
PHD2-dependent downregulation of VCAM-1 does not affect VE-cadherin expression. 68
BM pro-inflammatory cytokines do not contribute to VCAM-1 lower expression. 69
During steady-state, loss of VCAM-1 increased frequency BM resident mature cells. 69
BM-ECs VCAM-1 deficient mice 71
VCAM1EC mice developed leukocytosis. 71
VCAM1EC does not exhibit significant changes in hematopoiesis. 73
P2EC vessel morphology is independent of downregulation of VCAM-1 74
VCAMEC mice showed increased tumor homing in the diaphysis. 75
PHD2-HIF-2 regulatory effect on VCAM-1 is modulated by mir-126-3p. 76
HIF-2α regulates mir-126 expression in PHD2 deficient BM-ECs. 77
BM-ECs PHD2 influence bone homeostasis. 78
Loss of BM-ECs PHD2 lead to increase Osteoclast numbers and activity. 79
Osteoclast differentiation and activity could be independent of OBs. 79
Loss of PHD2 in BM-ECs leads to osteoclastogenesis. 80
BM resident Tcell CD8+ could be Increasing Osteoclast Activation. 82
Discussion. 83
Mouse Model: Conditional Deletion of Endothelial PHD2. 85
Endothelial PHD2 Modulates Myelopoiesis. 86
BM-EC PHD2 regulates vessel morphology and functionality under steady-state independent of VCAM-1. 88
Endothelial VCAM-1 downregulation does not impaired neutrophil migration during inflammation. 88
BM-ECs PHD2 is a Gatekeeper of Tumor Homing in the Bone. 89
HIF-2α dependent Mir-126 activation leads to VCAM-1 downregulation 91
Endothelial PHD2 controls Osteoclastogenesis independent of BM RANKL. 94
References 96
List of Abbreviations 107
Summary 109
Zusammenfassung 111
Acknowledgements 113
Deklaration 114
Appendix 118
List of Figures. 118
List of tables 119
|
718 |
The role of Rho GTPases in hematopoietic stem cell biology: RhoA GTPase regulates adult HSC engraftment and Rac1 GTPases is important for embryonic HSC migrationGhiaur, Gabriel 23 April 2008 (has links)
No description available.
|
719 |
THE ROLE OF MYELOID GSK3α/β IN ATHEROSCLEROSIS AND ATHEROSCLEROTIC REGRESSION / GSK3α/β IN ATHEROSCLEROSISPATEL, SARVATIT January 2022 (has links)
Atherosclerosis is a major underlying cause of cardiovascular disease; however, the molecular mechanisms by which cardiovascular risk factors promote the development of atherosclerosis are poorly understood. Recent evidence from our laboratory suggests that endoplasmic reticulum (ER) stress signaling through glycogen synthase kinase (GSK)-3α/β is involved in the activation of pro-atherosclerotic processes. Previous studies from our lab show that myeloid-specific deletion of GSK3α attenuates the progression of atherosclerosis. However, the precise role(s) of GSK3α/β in atherosclerotic regression is not known. The primary goal of this thesis is to investigate the role(s) of GSK3α/β in lesional macrophages and atherosclerotic regression.
Initially, we have targeted the ER stress- GSK3α/β pathway by supplementing the drinking water of low-density lipoprotein receptor (Ldlr)-/- mice with the small molecules 4-phenylbutyric acid or valproate. The results suggest that ER stress or GSK3α/β inhibition can attenuate the growth of existing atherosclerotic lesions and appear to increase lesion stability. From this study it remains unclear whether these interventions can promote atherosclerotic regression.
Next, to investigate the role(s) of GSK3α/β in pro-atherogenic processes, bone marrow derived macrophages were isolated from myeloid-specific GSK3α- and/or GSK3β-deficient mice. The effects of GSK3α/β-deficiency on signaling pathways regulating atherogenic functions in macrophage were analyzed. This study revealed that GSK3α and GSK3β play distinct, and often opposing roles in macrophage polarization, inflammatory response, lipid accumulation and migration. Furthermore, both GSK3α and GSK3β appear to play redundant roles macrophage viability, proliferation, and metabolism.
Lastly, we investigated the effect of macrophage-specific deletion of GSK3α and/or GSK3β on atherosclerotic regression in Ldlr−/− mice. A novel inducible knock out mouse model has been created in which GSK3α and/or GSK3β expression can be ablated by treating the mice with tamoxifen. These mice were fed a high fat diet to promote the development of atherosclerosis, and then mice were treated with tamoxifen to induce GSK3α/β deletion and switched to a chow diet for 12 weeks. All mice were sacrificed at 33 weeks of age and atherosclerotic plaques were analysed. Female mice with induced macrophage-specific GSK3α deficiency, but not GSK3β deficiency, showed regression of existing atherosclerotic lesions.
Together, these studies begin to delineate the specific roles of GSK3α and GSK3β in atherosclerotic regression. Furthermore, these data suggest that GSK3α inhibition could be an effective strategy for the treatment of atherosclerotic cardiovascular disease. / Thesis / Doctor of Philosophy (PhD) / Atherosclerosis is a disease involving the build-up of fatty plaques in the arteries, making them hard and narrow, which leads to damage in the heart, coronary or peripheral blood vessels. This can cause acute cardiovascular complications (heart attacks or stroke) and potentially death. We suspect that protein named glycogen synthase kinase (GSK)-3α/β is involved in the development of atherosclerosis. The purpose of this research is to see if we can treat atherosclerosis by blocking GSK3α/β’s functions. The findings of this study demonstrate that blocking GSK3α reduces inflammation, which is a primary cause of atherosclerosis. Furthermore, blocking GSK3α promotes the regression of atherosclerotic plaques and may lower the risk of cardiovascular disease. This knowledge could aid in the development of medications to treat atherosclerosis and reduce the number of individuals who die from heart attacks or strokes.
|
720 |
Functional characterization of asymmetric cell division associated genes in hematopoietic stem cells and bone marrow failure syndromesChan, Derek January 2020 (has links)
Hematopoietic stem cells (HSCs) are critical to the development of the hematopoietic system during ontogeny and maintaining hematopoiesis under steady-state. Several genes implicated in asymmetric cell division (ACD) have been found to influence HSC self-renewal in normal hematopoiesis and various leukemias. From a separate survey of genes associated with ACD, I now present the results from dedicated functional studies on two genes – Arhgef2 and Staufen1 – in HSCs and identify their potential contributions to benign hematopoietic disorders. Specifically, I present evidence that demonstrates a conserved role of Arhgef2 in orienting HSC division, the loss of which leads to HSC exhaustion that may underlie and contribute to the pathogenesis of Shwachman-Diamond syndrome. I also identify Staufen1 as a critical RNA-binding protein (RBP) in HSC function, downregulation of which elicits expression signatures consistent with clinical anemias reminiscent of aplastic anemia and/or paroxysmal nocturnal hemoglobinuria. I end by reviewing how RBPs function in HSCs and discuss future research directions that could further elucidate how bone marrow failure syndromes arise at the stem cell level. / Thesis / Doctor of Philosophy (PhD)
|
Page generated in 0.0473 seconds